Hyperhemolysis syndrome in patients with sickle cell anemia: Report of three cases

Transfusion

Volumn 55, Issue 6, 2015, Pages 1394-1398

  Santos, Berta ^a   Portugal, Rodrigo ^a   Nogueira, Carmen ^a   Loureiro, Monique ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; AMINOTRANSFERASE; AZITHROMYCIN; BILIRUBIN; CEFEPIME; ERYTHROPOIETIN; HEMOGLOBIN; HYDROCORTISONE; HYDROXYUREA; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; PIPERACILLIN; PREDNISONE; TAZOBACTAM; ANTIINFECTIVE AGENT; PENICILLANIC ACID;

ACUTE CHEST SYNDROME; ADOLESCENT; ARTICLE; BRAIN ISCHEMIA; CASE REPORT; COOMBS TEST; DYSPNEA; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; EXTRAMEDULLARY HEMATOPOIESIS; FEVER; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HOSPITAL ADMISSION; HUMAN; HYPERHEMOLYSIS SYNDROME; LEG PAIN; LEG ULCER; LEUKOCYTOSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RESPIRATORY TRACT INFECTION; SICKLE CELL ANEMIA; SPLEEN INJURY; SPLEEN SIZE; SPLENOMEGALY; TACHYCARDIA; THROMBOCYTOPENIA; ANALOGS AND DERIVATIVES; ANEMIA, HEMOLYTIC; ANEMIA, SICKLE CELL; COMPLICATION; PHYSIOLOGY; RETROSPECTIVE STUDY; SYNDROME;

ADOLESCENT; ANEMIA, HEMOLYTIC; ANEMIA, SICKLE CELL; ANTI-BACTERIAL AGENTS; ERYTHROCYTE TRANSFUSION; HEMOLYSIS; HUMANS; MALE; PENICILLANIC ACID; PIPERACILLIN; RETROSPECTIVE STUDIES; SYNDROME;

EID: 84931562898     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12993     Document Type: Article

References (26)

1. Win N, Doughty H, Telfer P, et al., Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 2001; 41: 323-8.
2. Talano JA, Hillery CA, Gottschall JL, et al., Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003; 111 (6 Pt 1): e661-5.
3. de Montalembert M, Dumont MD, Heilbronner C, et al., Delayed hemolytic transfusion reaction in children with sickle cell disease. Haematologica 2011; 96: 801-7.
4. Win N,. Hyperhemolysis syndrome in sickle cell disease. Expert Rev Hematol 2009; 2: 111-5.
5. Yan M, Callum J, Lin Y,. Hyperhemolysis associated with marginal zone lymphoma. Leuk Lymphoma 2014; 1-3.
6. Scheunemann LP, Ataga KI., Delayed hemolytic transfusion reaction in sickle cell disease. Am J Med Sci 2010; 339: 266-9.
7. Petz LD, Calhoun L, Shulman IA, et al., The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997; 37: 382-92.
8. Allen U, MacKinnon U, Zipursky HA, et al., Severe thrombocytopenia in sickle cell crisis. Pediatr Hematol Oncol 1988; 5: 137-41.
9. Ojuawo A, Adedoyin MA, Fagbule D,. Hepatic function tests in children with sickle cell anaemia during vaso-occlusive crisis. Cent Afr J Med 1994; 40: 342-5.
10. Kehinde MO, Jaja SI, Adewumi OM, et al., Liver enzymes and trace elements in the acute phase of sickle cell anaemia. West Afr J Med 2010; 29: 244-8.
11. Rogers ZR, Wang WC, Luo Z, et al., BABY HUG. Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG trial. Blood 2011; 117: 2614-7.
12. Samuels LD, Stewart C,. Estimation of spleen size in sickle cell anemia. J Nucl Med 1970; 11: 12-4.
13. Adekile AD, McKie KM, Adeodu OO, et al., Spleen in sickle cell anemia: comparative studies of Nigerian and U.S. patients. Am J Hematol 1993; 42: 316-21.
14. Al-Salem AH, Al-Aithan S, Bhamidipati P, et al., Sonographic assessment of spleen size in Saudi patients with sickle cell disease. Ann Saudi Med 1998; 18: 217-20.
15. Abjah UM, Aken'Ova YA,. Levels of malaria specific immunoglobulin G in Nigerian sickle cell disease patients with and without splenomegaly. Niger J Med 2003; 12: 32-8.
16. Durosinmi MA, Salawu L, Ova YA, et al., Haematological parameters in sickle cell anaemia patients with and without splenomegaly. Niger Postgrad Med J 2005; 12: 271-4.
17. Singh S, Singh DK, Gupta R, et al., Persistent splenomegaly in an adult female with homozygous sickle cell anemia. Hematology 2006; 11: 63-5.
18. Walker TM, Serjeant GR,. Focal echogenic lesions in the spleen in sickle cell disease. Clin Radiol 1993; 47: 114-6.
19. Hannema SE, Br A, van Meurs A, et al., Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with beta-thalassemia: challenges in treatment. Transfusion 2010; 50: 429-32.
20. Al-Salem AH,. Indications and complications of splenectomy for children with sickle cell disease. J Pediatr Surg 2006; 41: 1909-15.
21. Mouttalib S, Rice HE, Snyder D, et al., Evaluation of partial and total splenectomy in children with sickle cell disease using an Internet-based registry. Pediatr Blood Cancer 2012; 59: 100-4.
22. Owusu-Ofori S, Hirst C,. Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease. Cochrane Database Syst Rev 2013; 5: CD003425.
23. Bachmeyer C, Maury J, Parrot A, et al., Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia. Am J Hematol 2010; 85: 91-2.
24. Noizat-Pirenne F, Bachir D, Chadebech P, et al., Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease. Haematologica 2007; 92: e132-5.
25. Cattoni A, Cazzaniga G, Perseghin P, et al., An attempt to induce transient immunosuppression pre-erythrocytapheresis in a girl with sickle cell disease, a history of severe delayed hemolytic transfusion reactions and need for hip prosthesis. Hematol Rep 2013; 5: 36-8.
26. Uhlmann EJ, Shenoy S, Goodnough LT,. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion. Transfusion 2014; 54: 384-8.